Header
SABPA Newsletter, September 2017
In This Issue
Upcoming Events
SABPA Pacific Forum and Bio-partnering Event
Connect With Us
 
Subscribe to our WeChat 

SABPA Announcement

Outcome of the SABPA 2017 Board Election!
The SABPA Board of Directors (BOD) is the governing body that oversees the activities of SABPA organization. There are twenty-one (21) board directors for a three-year term. In 2017, seven (7) director seats were open for candidates seeking re-election and new election. Nine (9) SABPA member-nominated and qualified candidates entered the election this year. Based on the votes, the following candidates were elected as board directors (alphabetical order) in 2017: Hui Li, Ming Guo, Peter Zhu, Stephanie Shi, Xuefeng Zhu, Yahu Liu, and Yinghong Gao.

The 2017 SABPA BOD Election Committee sincerely thank all candidates for their strong leadership and remarkable contribution to SABPA‘s success and their participation in 2017 SABPA BOD election. The committee are also grateful to SABPA members for the involvement. Congratulations to re-elected and newly elected directors!

2017 SABPA BOD Election Committee

SABPA Events

13th SABPA Pacific Forum and 5th SABPA Bio-Partnering

Register at http://www.sabpa.org/registration-2/

5th SABPA Bio-Partnering

Paralleled with Pacific Forum, Hilton Del Mar, Sept. 30, 2017
Co-Organizers: SABPA, ChinaBio
 
SABPA Bio-Partnering is a great platform to explore the opportunities of licensing, investment, fund raising and other collaboration deals.  It is designed for you to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors/entrepreneurs by using the EBD online tool Partnering360*.  Participants can upload their profile to the platform, and send invitations to other participants.   Once the invitations are accepted, the 30 min private meetings will be arranged automatically.   Participants have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360 database all year round.   Bio-Partnering will be hosted at the same time and in the same venue with SABPA Pacific Forum (09/30/2017).  Please check the link below for more details.
Who shall attend?
  • Entrepreneurs and executives from local biotech and pharmaceutical companies
  • Chinese pharmaceutical companies who are looking for collaboration opportunities
  • Investors from local firms and across Pacific
  • Biotech or pharmaceutical service providers
Current and Previous Participating Organizations
Investors
  • GF-Bay City Capital International Life Sciences USD Fund
  • Qiming US Healthcare Venture Fund
  • Illumina Ventures
  • Ally Bridge Group
  • HuaQi Capital
  • Proxima Ventures
  • Venus Capital Fund
Companies
  • AbbVie
  • Eli Lilly
  • Johnson & Johnson Innovation
  • Theragene Therapeutics
  • Kelun Pharma
  • CTTQ Pharma
  • Simcere
  • Denovo Biopharma
Incubators
  • 中山市健康科技产业基地发展有限公司
  • Sino-Singapore (Chengdu) Innovation Park Development Co
  • Songshan Lake
  • TEDA
  • HEDA
How to Participate?
1. Register SABPA Bio-Partnering event and SABPA Pacific Forum at the link below:
      ($100, online only, complimentary admission to SABPA Pacific Forum included)
2. Receive a private Partnering360 log-in link sent by Whova after your registration
3. Access Partnering360 to setup your profile and schedule meetings. Step-by-step instruction is available here:     http://www.sabpa.org/1on1instruction2017/
4. Please act early to allow time for meeting arrangement (> 2 weeks prior to the event date)
Need Help? Please email: bio1on1@sabpa.org
* Partnering360 is a 3rd party (EBD Group) online software used to schedule meetings for SABPA Bio-Partnering.
Join SABPA LinkedIn Group Now
And receive $15 discount for the registration of Pacific Forum
Are you seeking to connect with hundreds of professionals in San Diego biotechnology and pharmaceutical industry? Do you wish to explore new employment and business opportunities through LinkedIn? Are you planning to participate in the 13th SABPA Pacific Forum that will take place on September 30th at Del Mar Hilton Hotel?
You are welcome to join SABPA Linkedin group! Now as a new member, you can register for the 13th SABPA Pacific Forum with $15 discount if you join by September 25th!
To get the discount code:
1. Join SABPA LinkedIn group at https://www.linkedin.com/groups/118216 before September 25th.
2. Once the new membership is approved, you will receive a confirmation email containing the discount code within 24 hours.
3. Enjoy the $15 discount for registration at http://www.sabpa.org/registration-2/
($30 for general admission, $15 for students and postdocs after discount, the fees include program brochure, continental breakfast, coffee break and lunch, parking is free)

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
About SABPA
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.